NYMC Faculty Publications
DOI
10.1177/2324709617732797
Journal Title
Journal of Investigative Medicine High Impact Case Reports
First Page
2324709617732797
Document Type
Article
Publication Date
9-1-2017
Department
Medicine
Abstract
Thrombotic microangiopathy (TMA) describes a pathological process of microvascular thrombosis, consumptive thrombocytopenia, and microangiopathic hemolytic anemia, leading to end-organ ischemia and infarction, affecting particularly the kidney and brain. TMA is a pathological feature of a number of clinical disorders including thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and atypical hemolytic uremic syndrome. Rare but important, TMA may also occur in malignancy, connective tissue disease, malignant hypertension, and renal transplantation (rejection or drug toxicity). We present a very rare case where the patient developed acute kidney injury from TMA but found to have multiple myeloma as the possible underlying etiology.
Recommended Citation
Chugh, S., Kichloo, A., Jafri, F., Yusvirazi, L., & Lerner, R. (2017). Multiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity. Journal of Investigative Medicine High Impact Case Reports, 5 (3), 2324709617732797. https://doi.org/10.1177/2324709617732797
Publisher's Statement
Originally published in Journal of Investigative Medicine High Impact Case Reports, 5 (3), 2324709617732797.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
